ABOUT US
Mabqi is a fully integrated immunotherapy biopharmaceutical company, using its cutting-edge antibody discovery platform to identify and develop breakthrough proprietary therapeutic molecules. Our current pipeline is composed of best in class and first in class assets for urgent and unmet medical needs.
Mabqi works in tandem with its corresponding academic platform “GenAc” and Inserm lab for very active research and R&D collaboration to continuously improve and innovate in our methods and tools.
Management team
Our team consolidates management excellence and best in class scientific expertise that can be traced back to the founding of fully human antibody phage display libraries.
Bernard Pau PhD
Sylvain Yon PhD
Gautier Robin PhD
Maxime Waldron
Anne Chevrel PhD. M. Eng
Johanna Marines PharmD. PhD. M. Eng
Medical Advisory Board
Created in 2021, Mabqi Medical Advisory Board is composed of 4 International experts who provide medical and economic insight to identify and validate promising therapeutic targets with high clinical need.